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  CLINICAL CASE STUDY  
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Buruli ulcer is an endemic condition in Ghana, and is second only to leprosy in terms of societal economic 
impact and the devastating disfigurement its pathological progression inflicts. However, it receives little 
attention in the Western world.  
This article raises awareness of Buruli ulcer in the worst affected region of the Ga West municipality in 
Ghana, as well as a broad overview of its profile in practice from the perspective of those living with the 
condition.  
 
History and Global Distribution of Buruli ulcer  
Buruli ulcer is a neglected yet common sub-tropical disease caused by the Mycobacterium ulcerans 
bacterium.1 It was first formally identified in the late 1890s by Sir Albert Cook, a missionary doctor, in the 
Ugandan district of Buruli.2 Despite its origins, there have been no reported incidences of Buruli ulcer in 
Uganda since the 1980s.3 In Australia, the condition became known as both Bairnsdale ulcer and Daintree 
ulcer in the 1930s due to its prevalence in these regions.4  
Inconsistency in its clinical presentation, recognition and the limited clinical diagnosis by health workers 
makes accurate prevalence rates a challenge to establish in several other countries.5 Cases of Buruli 
ulceration have been formally diagnosed and recorded in over 30 countries but central and western Africa 
still record the highest endemic rates.16 Twelve of the 15 endemic countries that provide the World Health 
Organization with clinical updates on the epidemiology of the disease reported almost 2200 newly 
detected cases in 2013.15  
In Cameroon, there is a prevalence rate of almost 0.5% involving both active and inactive cases, and 930 
cases are detected annually.6 Since 2015, Côte d’Ivoire had recorded more than 5000 cases of Buruli 
ulcer.7 Togo, Benin, Burkina Faso and Guinea have also reported increasingly high incidence rates.9 Buruli 
ulcer is rarely diagnosed in countries such as the USA, Europe and Canada, and cases that are detected are 
usually attributable to contraction of infection by travellers who have visited endemic regions of West 
Africa.10  
Ghana is the most highly endemic country, with increasing prevalence rates of 87 per 10,000 recorded in 
the Ga West Municipality alone.11 The major endemic feature of Mycobacterium ulcerans inhabitation is 
the presence of swampy and subtropical landscape.17 Several studies regarding transmission of Buruli 
ulcer in Ghana have verified a link between inhabitants who use the Densu River as their major water 
supply and the likelihood of being infected with the disease.12 Around 70% of the cases detected annually 
are inhabitants who live close to the Densu river, which has been identified as a centre of transmission.13  
Distribution of Buruli ulceration globally is indicated in Figure 1, illustrating endemic areas and those with 
a high incidence of the condition.  
Figure 1: Distribution of Buruli ulcer Globally  
INSERT FIGURE 1.  
Aetiological Factors and Clinical Manifestation of Buruli ulcer  
Buruli ulcer affects people of all ages, but children aged 1-15 years account for the highest incidence 
rates.18 In West Africa, Buruli ulcer is strongly associated with poverty and its association with little or no 
access to formal education.19 The disease commonly affects residents living or working in poor rural 
communities with restricted access to physical healthcare resources.22 In Ghana, although hospital 
treatment is free, the vast majority of Buruli ulcer patients and their families and carers cannot sustain the 
financial constraints that the condition imposes, such as paying for basic dressings, due to their poor 
socio-economic circumstances. Recent research conducted in Ghana reveals that more than 60% of 
families cannot afford to support a relative with Buruli ulcer, which consequently leads to patient isolation 
during care.21  
Localised Endemic Regions in Ghana  
In endemic areas, trained healthcare professionals detect and diagnose Buruli ulcer before sufferers are 
referred for formal diagnosis and management. The main confirmation tests for Buruli ulcer are IS2404 
Polymerase Chain Reaction (PCR), direct microscopy, microbial culture, histopathology and the Ziel Nelson 
(ZN) stain. PCR is the most commonly used method because of its sensitivity and the speed with which 
results are provided (within 48 hours).29  
The Ga West Municipality forms one of ten districts in the Greater Accra region of West Accra; Ghana’s 
capital. It has an estimated population of 550,000, and has a land area of about 692km2. The majority of 
the inhabitants are subsistence farmers, 30 so sand weaning is a common practice. This has led to the 
development of numerous surface bodies of water, which are commonly used for activities such as 
farming and minor fishing; they are also a haven for water-borne diseases such as Buruli ulcer, malaria 
and schistosomiasis.31 Less than 40% of the inhabitants have a sanitised water supply, with the majority 
depending on ponds, streams and the River Densu for their direct water supply in both agricultural and 
domestic contexts. As a direct consequence, diseases such as respiratory infection and diarrhoea are 
commonplace.32  
Poor road networking has led to decreased access to health provision and other significant socioeconomic 
activities such as educational provision, markets and churches, so many of the inhabitants often seek 
herbal remedies as first aid to the onset of their ailments.33  
Mode of Transmission  
The Mycobacterium ulcerans organism has been positively identified in swampy and waterlogged areas, 
and areas adjacent to rivers.23 The disease can actively thrive in these ideal conditions that ensure its 
survival and reproduction.24 Environmental changes such as deforestation, dam construction and 
agricultural activities have also been reported to increase numbers of the organism significantly. 25 Its 
mode of transmission is unclear, but several studies have suggested the involvement of certain aquatic 
insects, especially Naucoris dymploychus, however this has yet to be  
 
proven. Most recent evidence indicates transmission via breeches in epithelial tissue.26 There is not yet 
any evidence of transmission from person to person. 27  
Clinical Pathology  
Buruli ulcer can appear on any anatomical region of the body, with greatest incidence of infection in the 
lower limb. This is predominantly due to more frequent lower limb exposure to areas of soil and 
vegetation.  
The development of the condition is characterised by two stages; pre-ulcerative and ulcerative stage. The 
pre-ulcerative stage is characterised by a painless, anatomically fixed nodule, papule, oedema and the 
plaque. The frequent appearance of these lesions on the lower limb is attributed to contact of the legs 
with stagnant water. The World Health Organisation estimates that 35% and 55% of cases recorded 
appear on the upper and lower limbs respectively, whiles the remaining 10% appears on other anatomical 
sites.34  
Lesions are classified according to their size, characteristic appearance and anatomical location in three 
broad categories:  
1. Category I: a single lesion measuring less than 5cm in diameter.  
2. Category II: a lesion measuring between 5 and 15cm.  
3. Category III: a single lesion measuring more than 15cm that appear at critical sites such as the breast, 
eye and genitalia.  
 
A single Buruli ulcerative lesion large numbers of the Mycobacterium ulcerans organism, usually in clusters 
or in smaller units at the centre of the lesion (Thangarag et al, 1999 –AUTHOR: THIS DOES NOT APPEAR IN 
REF LIST). Mycobacterium ulcerans produces mycolactone, a toxin with cytotoxic and analgesic properties, 
which make the established lesion painless.36 As the disease progresses, surrounding structures such as 
nerves and blood vessels become progressively infected.37 The appearance of these granulomas (which 
contain epithelial and Langhan’s Giant cells) is a clear indication that the immune response of the patient 
has a significant role in the elimination of the organism from the body.38  
All phases of disease progression predispose the patient to the risk of developing the secondary ulcerative 
stage if they are not detected and treated early. Due to the painless nature of the pre-ulcerative stage, 
most affected patients ignore its presence but become more alarmed at the secondary ulcerative stage. 
Painful ulceration develops as a direct result of the underlying infection; it may spread to destroy 
extensive areas of the dermis and, in the most severe instances, affect bone tissue. This, in turn, leads to 
the formation of permanent limb contractures. These contractures lead to permanent disability in the 
majority of cases. Some ulcers do heal without intervention but only if the surrounding anatomical and 
physiological structures remain unaffected by the infective organism.40  
Figure 2: Clinical Manifestations of Buruli ulcer  
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Source: (World Health Organisation, 2000).  
Local Healthcare Infrastructure and Buruli ulcer  
Ga West Municipal Hospital (GWMH) which is located in the municipality’s capital (Amasaman), is the 
major surgical and referral centre for Buruli ulcer. Though this hospital is in an area ranked the fifth most 
endemic Buruli ulcer district in Ghana, it records the highest case-loads in terms of active and healed 
lesions.41,42 The Buruli ulcer unit was established by World Vision Ghan, and each year up to 90 patients 
are admitted for long-term treatment.42 One of the major pre conditions for admission to the unit is the 
identification of a carer who will take responsibility for the patient until discharge. The unit is made up of 
a team of doctors, lab technicians, nurses, researchers, care assistants and physiotherapists. Wound 
dressing is undertaken twice weekly for both inpatients and outpatients, although daily dressings are 
often advocated depending on the condition of the wound.43  
Socio-cultural Overview of Buruli ulcer  
The literature around the socio-cultural impact of Buruli ulcer highlights an array of experiences in relation 
to physical symptoms, emotional coping mechanisms and the wider psychological and social impacts of 
the condition.44 Poor recognition of the initial symptomology of the illness, coupled with a delay in the 
identification of the illness and delay in seeking treatment, culminates in poor compliance with 
recommended treatment regimens.45  
Culturally women suffer less social isolation in relation to Buruli ulcer infection than men, who are less 
likely to seek treatment at any stage of the disease, despite being most likely to be the main wage earner 
in Ghanaian culture.46 Social life in Ghana often revolves around leisure activities centred in swimming, 
gardening or travelling (Brown, 2005). Stigmatisation due to wound appearance and the resultant 
disabilities that can occur as a direct result of the condition means that sufferers become increasingly 
socially isolated.47  
Culturally in the Ga West municipality, Buruli ulcer is believed to have supernatural origins, although a 
small sector of the local population do acknowledge swimming in rivers or ponds as a risk factor.48 Since 
knowledge of the condition’s origins has a significant impact on whether people seek medical intervention 
or use witchcraft to oust it, significant delays in patients receiving orthodox medical diagnosis and 
intervention are common.49 It has been locally reported that 51% of their respondents attribute the cause 
to witchcraft, sorcery and curses. Social sigmatisation in relation to perceived supernatural punishment or 
negatively deserved karma surrounding people with the condition also provides an insight into why 
sufferers or their families and carers do not seek help.50  
Significant delays in seeking medical aid are also associated with perceptions of the disease’s prognosis, in 
particular the belief that diagnosis will automatically lead to a referral for amputation of affected limbs.51 
Lack of pain on a pragmatic level also means that, since sufferers are not in any significant discomfort, 
their everyday activities can continue largely unhindered until the more pronounced ulcerative phase of 
the disease.52  
Carer Designation  
 
Carers can be defined as those who provide support and assistance to Buruli ulcer patients, ranging from 
practical help with dressings to the provision of psychological support and spiritual aid. Carers are 
predominantly 50 years of age or older, female, and usually are immediate relatives of the sufferer. Carers 
are often involved in health promotion and are a valuable resource to the local community in reducing 
recurrence of tropical disease. The burden of being a carer in such circumstances can be stressful, and 
often attributed to poor communication with healthcare providers and the practicalities of providing care 
in an inpatient setting.54 Prognostic outcomes of Buruli ulceration are positively impacted upon by the 
presence of carers. The average time spent as an inpatient for Buruli ulcer patients and their carers is 91 
days, and nearly all treatments centres regard carer accompaniment as a mandatory requirement as part 
of the admissions protocol.55  
Fiscal Implications of Buruli ulcer  
In addition to the cost to the national economy in Ghana, Buruli ulcer has a much greater impact at a 
micro-level for affected patients. Their carers and families suffer increasing poverty in relation to the 
socio-economic impact of the disease.56 Recent cost analysis study reveals that, despite the availability of 
free medical care, Buruli ulcer households are still faced with unmanageable costs due to the need to 
provide regular dressing packs for their relatives. Most households with a low income react to this by 
withdrawing from care and returning to traditional herbalists for treatment. This is not surprising when 
the average expense of Buruli ulcer hospital treatment is estimated to be 25% of the average family’s 
household annual income.57  
Control Programmes  
The World Health Organisation in collaboration with the Global Buruli ulcer Initiative has outlined several 
control measures to be implemented at a local community level, alongside the established operational 
treatment pathways already available.58 Education lies at the heart of these interventions, which include:  
Implementation of an early clinical case detection protocol  
Empowering community health workers through education and training in Buruli ulcer care  
Proactive management of confirmed cases via medical and surgical intervention as required and  
The prevention of long term disability via ongoing processes of rehabilitation  
Improved standards of diagnosis in the confirmation of cases via an efficient laboratories 
infrastructure  
The use of standard Buruli ulcer record forms to accurately report all cases detected  
Strengthening healthcare infrastructure  
Establishing an effective monitoring and evaluation of control actions (World Health Organisation, 
2001)  
 
Fig 3: Creating Buruli ulcer Awareness with Community Members in an Endemic Village in the Ga West 
Municipality, Ghana.  
INSERT FIGURE 3  
Source: National Buruli ulcer Control Programme  
The National Buruli ulcer Control Programme (NBUCP) was established in Ghana in 2002 as a consequence 
of the Yamoussoukro Declaration, which enforced control programmes in all countries where Buruli 
ulceration was endemic.59 In Ghana, the NBUCP continues to raise awareness of Buruli ulcer for all health 
workers and the general public. It also seeks to collaborate with health service providers and trains 
community volunteers who help in the detection and screening of cases early enough to prevent 
complications or disability. As part of its aim, NBUCP intend to train health personnel to improve case 
management skill and collaborate with research institutions to conduct detailed studies on Buruli ulcer.  
Conclusion  
Buruli ulcer remains an endemic condition in Ghana, yet the impact of the disease receives little attention 
in the Western world. It is second only to leprosy in terms of societal economic impact and the 
devastating disfigurement its pathological progression inflicts. The fact that, socioculturally, Buruli ulcer is 
also entrenched in supernatural belief remains a challenge.  
In a country where podiatric medicine is not a recognised allied health profession, raising awareness is 
one of the first steps the podiatry profession can make to challenging and addressing this inertia in 
international support for the eradication of Buruli ulcer through tailored and affordable treatment 
interventions. Whether this happens as a direct result of financial aid or practical support is most certainly 
a debate for the global healthcare community and the politicians whose intervention can mediate this 
change.  
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